R-848 triggers the expression of TLR7/8 and suppresses HIV replication in monocytes

• Published in: BMC infectious diseases 2012-01, Vol.12 (1), p.5-5, Article 5
• Main Authors: Nian, Hua, Geng, Wen-Qing, Cui, Hua-Lu, Bao, Ming-jia, Zhang, Zi-ning, Zhang, Min, Pan, Ying, Hu, Qing-Hai, Shang, Hong
• Format: Article
• Language: English
• Subjects: Acquired immune deficiency syndrome; Adult; AIDS; Cells, Cultured; China; Female; Gene Expression Profiling; HIV; HIV - growth & development; HIV - immunology; HIV patients; Human immunodeficiency virus; Humans; Imidazoles - pharmacology; Immune system; Immunologic Factors - pharmacology; Male; Medical research; Middle Aged; Monocytes; Monocytes - immunology; Monocytes - virology; Physiological aspects; R-848; Studies; Toll-like receptor; Toll-Like Receptor 7 - biosynthesis; Toll-Like Receptor 7 - immunology; Toll-Like Receptor 8 - biosynthesis; Toll-Like Receptor 8 - immunology; Toll-like receptors; Virus Replication
• ISSN: 1471-2334; 1471-2334
• DOI: 10.1186/1471-2334-12-5

Toll-like receptors (TLR) 7 and 8 are important in single-stranded viral RNA recognition and may play a role in HIV infection and disease progression. We analyzed TLR7/8 expression and signaling in monocytes from HIV-infected and uninfected subjects to investigate a pathway with new potential for the suppression of HIV replication. Eighty-one HIV-infected and uninfected subjects from Liaoning and Henan provinces in China participated in this study. Monocytes were isolated from subjects' peripheral blood mononuclear cells by magnetic bead selection. TLR7 and TLR8 mRNA was measured using quantitative real-time reverse transcriptase PCR. R-848 (resiquimod) was used as a ligand for TLR7 and TLR8 in order to 1) assess TLR7/8-mediated monocyte responsiveness as indicated by IL-12 p40 and TNF-α secretion and 2) to examine HIV replication in cultured monocytes in the presence of R-848. We found that expression of TLR7/8 mRNA in peripheral blood monocytes decreased with disease progression. TLR7 expression was decreased with stimulation with the TLR7/8 agonist, R-848, in vitro, whereas TLR8 expression was unaffected. Following R-848 stimulation, monocytes from HIV-infected subjects produced significantly less TNF-α than those from uninfected subjects, but trended towards greater production of IL-12 than stimulated monocytes from uninfected subjects. R-848 stimulation also suppressed HIV replication in cultured monocytes. Our study provides evidence that the TLR7 and TLR8 triggering can suppress HIV replication in monocytes and lead to postpone HIV disease progression, thereby offering novel targets for immunomodulatory therapy.